UFP TECHNOLOGIES INC UFPT

Latest FY: 2025 Healthcare Medical Devices
Market Price $275.44
Market Cap $2.13B
P/E Ratio 31.48
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑19.5% YoY
$602.80M
3-Yr CAGR: 19.4%
Net Income ↑15.8% YoY
$68.31M
Net Margin: 11.3%
Free Cash Flow ↑61.3% YoY
$91.87M
FCF Yield: 4.31%
EPS (Diluted) ↑15.4% YoY
$8.75
Basic: $8.87
Return on Equity Efficiency
16.1%
ROA: 10.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (UFPT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $146.1M $34.6M $8.0M $1.10 0.00% $9.4M $2.1M
FY 2017 $147.8M +1.2% $35.5M $9.2M +15.6% $1.26 +14.5% 0.00% $17.5M $7.1M +237.5%
FY 2018 $190.5M +28.8% $48.3M $14.3M +55.4% $1.93 +53.2% 0.00% $21.3M $15.9M +124.2%
FY 2019 $198.4M +4.2% $54.0M $19.8M +38.0% $2.63 +36.3% 0.00% $31.2M $25.5M +60.1%
FY 2020 $179.4M -9.6% $44.7M $13.4M -32.3% $1.77 -32.7% 0.00% $25.0M $20.7M -18.8%
FY 2021 $206.3M +15.0% $51.1M $15.9M +18.8% $2.09 +18.1% 0.00% $14.3M $8.9M -57.0%
FY 2022 $353.8M +71.5% $90.3M $41.8M +163.1% $5.45 +160.8% 0.00% $17.7M $4.0M -55.5%
FY 2023 $400.1M +13.1% $112.2M $44.9M +7.5% $5.83 +7.0% 0.00% $41.3M $30.8M +678.1%
FY 2024 $504.4M +26.1% $146.7M $59.0M +31.3% $7.58 +30.0% 0.00% $66.6M $56.9M +84.6%
FY 2025 $602.8M +19.5% $170.4M $68.3M +15.8% $8.75 +15.4% 0.00% $91.9M $91.9M +61.3%
$

Valuation

Market Price $275.44
Market Cap $2.13B
Enterprise Value $2.25B
P/E Ratio 31.48
P/B Ratio 5.03
FCF Yield 4.31%
Dividend Yield N/A
Shares Outstanding 7,736,900
%

Profitability & Margins

Gross Margin 28.27%
Operating Margin 15.32%
Net Margin 11.33%
Return on Equity (ROE) 16.12%
Return on Assets (ROA) 10.43%
Asset Turnover 0.92x
Revenue 3-Yr CAGR 19.44%
🛡️

Financial Health & Liquidity

Current Ratio 2.68
Cash Ratio 0.27
Debt / Equity 0.320
Debt / Assets 0.207
Cash & Equivalents $20.30M
Total Debt $135.46M
Book Value / Share $54.79
💧

Cash Flow Efficiency

Operating Cash Flow $91.91M
Capital Expenditures (CapEx) $38.00K
Free Cash Flow $91.87M
OCF / Revenue 15.25%
FCF / Revenue 15.24%
FCF 3-Yr CAGR 185.11%
🏷️

Per Share Metrics

EPS (Diluted) $8.75
EPS (Basic) $8.87
Dividends / Share N/A
Book Value / Share $54.79
EPS YoY Growth 15.44%
🏛️

Balance Sheet (FY 2025)

Total Assets $655.08M
Total Liabilities $231.20M
Stockholders' Equity $423.88M
Current Assets $201.00M
Current Liabilities $74.86M